The secrets of the bone marrow niche: Metabolic priming for AML. (Q39363565)

11 September 2017

The secrets of the bone marrow niche: Metabolic priming for AML. (English)

1 reference

11 September 2017

3

David T Scadden

1 reference

11 September 2017

Rushdia Z Yusuf

1

1 reference

11 September 2017

Ying-Hua Wang

series ordinal

2

1 reference

11 September 2017

language of work or name

English

0 references

publication date

6 June 2012

1 reference

11 September 2017

1 reference

11 September 2017

18

1 reference

11 September 2017

6

1 reference

11 September 2017

865-867

1 reference

Clonal architecture of secondary acute myeloid leukemia

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

Clonal evolution in cancer

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

Altered hematopoietic cell gene expression precedes development of therapy-related myelodysplasia/acute myeloid leukemia and identifies patients at risk

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

Clinical effect of point mutations in myelodysplastic syndromes

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

Targeting HIF1α eliminates cancer stem cells in hematological malignancies.

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

The control of the metabolic switch in cancers by oncogenes and tumor suppressor genes

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

IDH2 mutations in patients with D-2-hydroxyglutaric aciduria

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

Recurring mutations found by sequencing an acute myeloid leukemia genome

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

Understanding the Warburg effect: the metabolic requirements of cell proliferation

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

The relationship between the spleen colony-forming cell and the haemopoietic stem cell

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

Tyrosine phosphorylation inhibits PKM2 to promote the Warburg effect and tumor growth

11 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4013790

Stromal control of cystine metabolism promotes cancer cell survival in chronic lymphocytic leukaemia

14 September 2017

1 reference

Crossref

https://api.crossref.org/works/10.1038%2FNM.2831

Therapy of secondary leukemia

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22673998

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

[Origin of cancer cells]

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/22673998

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1038/NM.2831

1 reference

11 September 2017

1 reference

11 September 2017

PubMed publication ID

22673998

1 reference